William C. Wood, MD | Authors

Breast Reconstruction in the Setting of Postmastectomy Radiotherapy: Controversies and Disparities

December 13, 2019

Breast reconstruction improves quality of life, but providers must be aware of the risks and benefits of each reconstruction approach in the setting of postmastectomy radiotherapy.

COUNTERPOINT: Should Radiation Therapy After Surgery for Ductal Carcinoma In Situ Be Standard Practice?

August 15, 2017

To universally recommend breast irradiation for all women after excision of DCIS lesions ignores information now available to us that can spare the majority of women with DCIS the downsides of RT, but be applied in the treatment of DCIS patients at greater risk for invasive disease.

The Current Clinical Value of the DCIS Score

May 15, 2014

The DCIS Score provides clinically relevant information about personal risk that can guide patient discussions and facilitate shared decision making.

Kinder, Gentler Cancer Therapy: Not So Fast

October 15, 2013

Kinder, gentler cancer therapy is neither of those things if it fails to be as effective in controlling the cancer. When an area of completely clinically regressed cancer is excised, there is commonly residual cancer present.

Ductal Carcinoma In Situ of the Breast: ‘Making the Punishment Fit the Crime’

August 15, 2013

To make the punishment fit the crime, you would want the decision of whether or not to use adjuvants to be informed by the degree of risk that the DCIS would recur. What factors can predict for an increased risk of recurrence, or more importantly, the risk of an invasive breast cancer occurring?

25 Years Later: Endangered Species or Successful Evolution?

December 16, 2011

While ONCOLOGY has continued to evolve along with the field of oncology-for example, it now addresses critical issues of science and socioeconomics-it has remained true to the founding principles. Perhaps largely for this reason, the journal continues to be widely read across the entire oncology community.

The Changing Field of Locoregional Treatment for Breast Cancer

August 15, 2011

Since 1990, death rates from breast cancer have decreased, mainly in women younger than 50 years of age (3.3% per year) vs women aged 50 years or older (2% per year), reflecting the benefit of widespread use of systemic treatment added to early detection.[1]

Retrospective on the Last Quarter-Century in Surgical Oncology

April 30, 2011

The past twenty-five years have seen a drop in deaths from cancer, particularly in the last half of that period.

Increasing Use of Contralateral Prophylactic Mastectomy: A Counterintuitive Trend

April 30, 2008

A recent study has provided evidence that the use of contralateral prophylactic mastectomy (CPM) is increasing